Menu Search
Equities

Fukuda Denshi Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
6960N:MEX

Fukuda Denshi Co Ltd

Actions
  • Price (MXN)863.33
  • Today's Change-83.52 / -8.82%
  • Shares traded2.64k
  • 1 Year change--
  • Beta0.5193
Data delayed at least 20 minutes, as of Oct 22 2024 12:30 BST.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

FUKUDA DENSHI CO., LTD. is a Japan-based company mainly engaged in manufacture, purchase and sale of medical electronic equipment. The Company operates in four business segments. The Biopsy Device segment mainly involves in the manufacture, trading and sales of electrocardiographs, ultrasound diagnostic imaging equipment, automated hemocytometers, etc. The Biological Information Monitoring segment involves in the manufacture, trading and sale of biological information monitors. The Therapy Apparatus segment involves in the manufacture, trading and sale of defibrillators, ventilators, pacemakers, catheters, home rental business, etc. The Consumable Supplies and Others segment provides the consumable goods of equipment for all segments as well as repair and maintenance services.

  • Revenue in JPY (TTM)138.47bn
  • Net income in JPY17.96bn
  • Incorporated1948
  • Employees3.47k
  • Location
    Fukuda Denshi Co Ltd3-39-4, HongoBUNKYO-KU 113-8483JapanJPN
  • Phone+81 338152121
  • Fax+81 338141222
  • Websitehttps://www.fukuda.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		6960:TYO since
announced		Transaction
value
M Heart Co LtdDeal completed30 May 202530 May 2025Deal completed29.76%--
Data delayed at least 15 minutes, as of Feb 06 2026 06:30 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.